logo
AI Iconš›¼SK or Search
ENTITY

GT Biopharma (GTBP US)

2
Analysis
Health Care ā€¢ United States
GT Biopharma, Inc. operates as a biotechnology company. The Company discovers, develops, and commercializes drugs of therapeutic molecules for the treatment of cancer, myeloma, osteolytic lesions, and other unmet medical needs. GT Biopharma serves customers worldwide.
more
bullishā€¢GT Biopharma
ā€¢12 Oct 2026 14:02

GT Biopharma (GTBP US): Synthetic Expert Call Transcript (12 Oct 2026)

GT Biopharma's TriKEĀ® platform differentiates itself from T-cell engagers (BiTEs) and CAR-NK cell therapies by delivering targeted natural killer...

Logo
Share
bullishā€¢GT Biopharma
ā€¢11 Oct 2026 10:00

IPO Databook: GT Biopharma (GTBP US) - Oct 2026

GT Biopharma, Inc. is a clinical stage biopharmaceutical company developing and commercializing novel immuno-oncology products using proprietary...

Logo
Share

Copyright Ā© 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4

x